secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2025-06-30T23:59:59+00:00
Accession:  0001213900-25-059690
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio raises ~$19M in registered direct offering of 3M shares at $6.30/sh
------------------------------------------------------------------------------

- Offering of 3,000,000 common shares at $6.30/share to two healthcare-focused institutional investors.
- Gross proceeds of approximately $19 million; net proceeds for working capital and general corporate purposes.
- A.G.P./Alliance Global Partners acted as sole placement agent; 7% cash fee paid.
- Pricing announced June 27, 2025; closing occurred June 30, 2025.
- Shares offered under effective shelf registration statement (Form S-3, File No. 333-279036).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025059690/0001213900-25-059690-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025059690/ea0247461-8k_inmune.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-059690

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer